These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3115165)

  • 41. [Lupus anticoagulant: an increasingly used marker].
    Castañeda Sanz S; Herrero-Beaumont G; Tornero Molina J; Aguado García JM; Outeiriño J
    Rev Clin Esp; 1985 Jun; 177(1):1-6. PubMed ID: 3929341
    [No Abstract]   [Full Text] [Related]  

  • 42. [The role of the thrombocyte and erythrocyte components of hemostasis in the development of thrombohemorrhagic complications in patients with systemic lupus erythematosus].
    Gritsiuk AI; Ivanova NV; Vas'kova NG; Kosiuk LN; Poltavets NI
    Vrach Delo; 1990 Dec; (12):21-3. PubMed ID: 2089792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The lupus anticoagulant, methodologic approaches to its determination].
    Prudnikova LZ; Saĭkovskaia TV
    Lab Delo; 1988; (8):38-40. PubMed ID: 2462115
    [No Abstract]   [Full Text] [Related]  

  • 44. Lupus anticoagulant and thrombosis in systemic lupus erythematosus.
    Jungers P; Liote F; Dautzenberg MD; Gazengel C; Dougados M; Tron F; Bach JF
    Lancet; 1984 Mar; 1(8376):574-5. PubMed ID: 6142298
    [No Abstract]   [Full Text] [Related]  

  • 45. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lupus anticoagulants.
    Sidor CF; Martin SE; Abel R; Blatt PM
    Del Med J; 1986 Apr; 58(4):239-45. PubMed ID: 3086143
    [No Abstract]   [Full Text] [Related]  

  • 47. Haemostatic abnormalities in systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Tozman EC; Glynn MF
    Q J Med; 1983; 52(207):424-33. PubMed ID: 6647751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Caval thromboses and systemic diseases].
    Fassin D; Wechsler B; Herson S; Godeau P
    Ann Med Interne (Paris); 1986; 137(6):456-60. PubMed ID: 3813279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon.
    Triplett DA; Brandt JT
    Hematol Pathol; 1988; 2(3):121-43. PubMed ID: 3146568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antinuclear antibody-negative systemic lupus erythematosus (SLE) and severe renal involvement: close correlation between disease activity and appearance of circulating anticoagulant.
    Raz E; Michaeli J; Rosenmann E; Rubinow A; Popovtzer MM
    Isr J Med Sci; 1988 Feb; 24(2):105-8. PubMed ID: 3128493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V
    J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Circulating anticoagulants and pregnancy: a risky combination].
    Dantal J; Dantal F; Sagot P; Lopes P; Lerat MF
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(3):317-24. PubMed ID: 3135300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lupus anticoagulant and cerebrovascular stroke].
    Montalbán J; Ordi J; Barquinero J; Dávalos A; Alijotas J; Codina A; Vilardell M
    Med Clin (Barc); 1988 Feb; 90(7):280-2. PubMed ID: 3129625
    [No Abstract]   [Full Text] [Related]  

  • 54. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
    Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe hemorrhage in a patient with circulating anticoagulant, acquired hypoprothrombinemia, and systemic lupus erythematosus.
    Small P
    Arthritis Rheum; 1988 Sep; 31(9):1210-1. PubMed ID: 3139005
    [No Abstract]   [Full Text] [Related]  

  • 56. [Recurrent abortions and circulating anticoagulant. Relation to lupic disease: 6 cases].
    Mathieu A; Piette JC; Blétry O; Conard J; Wechsler B; Le Bas J; Serdaru M; Godeau P
    Ann Med Interne (Paris); 1984; 135(7):502-6. PubMed ID: 6517421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombosis in systemic lupus erythematosus: a French collaborative study.
    Montes de Oca MA; Babron MC; Blétry O; Broyer M; Courtecuisse V; Fontaine JL; Loirat C; Méry JP; Reinert P; Wechsler B
    Arch Dis Child; 1991 Jun; 66(6):713-7. PubMed ID: 1905123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and laboratory observations in eight patients with lupus-type circulating anticoagulant.
    Canciani MT; Maspero ML; Cattaneo M; Mannucci PM
    Haematologica; 1979 Jun; 64(3):309-21. PubMed ID: 113299
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic lupus erythematosus circulating anticoagulant: report of a case.
    Haber-Cohen A; Burke JE
    J Oral Maxillofac Surg; 1988 Aug; 46(8):688-9. PubMed ID: 3135371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lupus anticoagulant].
    Huang ZL
    Zhonghua Nei Ke Za Zhi; 1988 May; 27(5):318-21. PubMed ID: 3143524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.